Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01198834Phase 3Completed
Phase 3, randomised, double-blind trial of etodolac and lidocaine in Ankle sprain (4 arms), sponsored by MEDRx. Primary endpoint: Mean of All Current Pain Intensity During Point and Flex Scores on Days 2 Through 7. Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01198834.